Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026.
- Largest single sale: $9.2M (19,662 shares) of Vertex Pharmaceuticals on Feb 19, 2026. Filing
- Last sale before this period: May 15, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Vertex Pharmaceuticals (VRTX) | EVP Chief Patient & Ext Af Off | Jul 24, 2007 | Jul 23, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jul 21, 2026, Vertex Pharmaceuticals: 8,251 shares granted. 1 filing: 1
- Feb 25, 2026, Vertex Pharmaceuticals: sold 1,846 shares for $898K, under a disclosed plan. 1 filing: 1
- Feb 24, 2026, Vertex Pharmaceuticals: 1,518 shares withheld by the company for taxes. 1 filing: 1
- Feb 19, 2026, Vertex Pharmaceuticals: sold 58,613 shares for $27.5M, under a disclosed plan; 48,505 shares acquired by exercising options. 1 filing: 1
- Feb 17, 2026, Vertex Pharmaceuticals: 5,789 shares granted; 2,140 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.